Proceedings Article | 4 April 2022
KEYWORDS: Tumors, Image segmentation, Brain, Magnetic resonance imaging, Neuroimaging, Brain mapping, Radiotherapy, Distance measurement, Cancer, Tissues
Multiparameter magnetic resonance imaging (mp-MRI) commonly used modality for segmentation of glioma and its subregions, whereas RT therapy is a commonly used treatment modality. Current workflow includes manual segmentation of brain tumor sub-regions, which is a very lengthy and laborious process given that different sets of MR images have to be analyzed for an appropriate diagnosis. This work focuses on implementing and testing feasibility of a new deep learning model for an automatic segmentation of brain tumor sub-regions. Our proposed method, named hierarchical substructural activation network, consists of three main parts: a detection and segmentation module, and a hierarchical convolutional block. While the detection module is employed to detect the view-of-interests (VOIs) of brain tumor, which include all tumor sub-structures, the hierarchical convolutional block is used to derive structural activation map (SAM) to boost the classification accuracy between different structures. This is followed by the semantic segmentation of each substructure within the detected VOI by segmentation module. Brain tumor segmentation challenge (BraTS) 2020 dataset was used for evaluating our proposed framework. We performed five-fold cross validation experiments on 100 BraTS datasets. Three substructures, i.e., necrosis and non-enhancing, edema, enhancing tumor (ET), tumor core (TC), were segmented and compared with manual contours using the Dice similarity coefficient (DSC) and mean surface distance (MSD). In terms of segmentation of necrosis and non-enhancing subregions, edema, ET and TC, our method yielded DSC of 0.69±0.24, 0.89±0.09, 0.80±0.14, and 0.88±0.11, respectively, and MSD of 2.01±2.75, 0.63±0.58, 0.98±1.10 and 1.74±1.06 mm, respectively. Preliminary results of this work show promise to both accurately and automatically segment brain tumor subregions by our proposed method, providing motivation for its clinical implementation to improve clinical workflow.
